|
GFM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.70790000000964E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.88279999999853E-07 |
| Normal-vs-Stage2 |
1.823030E-03 |
| Normal-vs-Stage3 |
1.885370E-01 |
| Normal-vs-Stage4 |
6.678300E-03 |
| Stage1-vs-Stage2 |
5.376200E-01 |
| Stage1-vs-Stage3 |
2.533600E-01 |
| Stage1-vs-Stage4 |
8.241600E-01 |
| Stage2-vs-Stage3 |
5.131000E-01 |
| Stage2-vs-Stage4 |
8.037600E-01 |
| Stage3-vs-Stage4 |
4.520600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.41090000005395E-06 |
| Normal-vs-AfricanAmerican |
1.988700E-04 |
| Normal-vs-Asian |
6.261200E-01 |
| Caucasian-vs-AfricanAmerican |
6.248400E-01 |
| Caucasian-vs-Asian |
2.806600E-01 |
| AfricanAmerican-vs-Asian |
3.044600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.57809999979631E-07 |
| Normal-vs-Female |
1.463990E-03 |
| Male-vs-Female |
1.210200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.62400000000607E-05 |
| Normal-vs-Extreme_Weight |
9.10720000524279E-08 |
| Normal-vs-Obese |
1.642290E-04 |
| Normal-vs-Extreme_Obese |
8.748100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.742200E-01 |
| Normal_Weight-vs-Obese |
5.612000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.792400E-01 |
| Extreme_Weight-vs-Obese |
1.854210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.887200E-01 |
| Obese-vs-Extreme_Obese |
9.306600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.537300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.037970E-04 |
| Normal-vs-Age(61-80Yrs) |
1.84371999999433E-05 |
| Normal-vs-Age(81-100Yrs) |
8.448900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.376800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.785600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.757400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.011600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.964800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.428000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.93459999925972E-08 |
| Normal-VS-Type2 PRCC |
2.607700E-02 |
| Normal-VS-KIRP CIMP |
3.014100E-04 |
| Normal-VS-Unclassified PRCC |
4.562700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.783900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.533400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.047800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.836000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.127600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.595000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.223800E-03 |
| Normal-vs-N1 |
1.862960E-03 |
| Normal-vs-N2 |
1.102490E-02 |
| N0-vs-N1 |
9.685000E-01 |
| N0-vs-N2 |
6.243400E-01 |
| N1-vs-N2 |
5.297800E-01 |
|
|
